Blood glutamate EAAT


Journal

EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 20 08 2018
revised: 13 11 2018
accepted: 13 11 2018
pubmed: 18 12 2018
medline: 14 6 2019
entrez: 18 12 2018
Statut: ppublish

Résumé

Excitatory amino acid transporter 2 (EAAT To address this hypothesis, EAAT The expression of EAAT Although the transfection procedure most likely interferes with some of the intrinsic protective mechanisms of mesenchymal cells, the results show that the induced expression of EAAT

Sections du résumé

BACKGROUND BACKGROUND
Excitatory amino acid transporter 2 (EAAT
METHODS METHODS
To address this hypothesis, EAAT
FINDINGS RESULTS
The expression of EAAT
INTERPRETATION CONCLUSIONS
Although the transfection procedure most likely interferes with some of the intrinsic protective mechanisms of mesenchymal cells, the results show that the induced expression of EAAT

Identifiants

pubmed: 30555045
pii: S2352-3964(18)30517-6
doi: 10.1016/j.ebiom.2018.11.024
pmc: PMC6354443
pii:
doi:

Substances chimiques

Excitatory Amino Acid Transporter 2 0
Glutamate Plasma Membrane Transport Proteins 0
SLC1A2 protein, human 0
Glutamic Acid 3KX376GY7L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-131

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Références

J Biol Chem. 1999 Nov 5;274(45):31891-5
pubmed: 10542215
Neurochem Int. 2007 Nov-Dec;51(6-7):333-55
pubmed: 17517448
Neuroscience. 2009 Jan 12;158(1):301-8
pubmed: 18423998
Cell Mol Neurobiol. 2009 Sep;29(6-7):827-35
pubmed: 19259807
J Leukoc Biol. 2010 Feb;87(2):283-9
pubmed: 19897767
J Biol Chem. 2011 Jan 21;286(3):1927-37
pubmed: 21097502
Clin Sci (Lond). 2011 Jul;121(1):11-7
pubmed: 21265738
J Cereb Blood Flow Metab. 2011 Jun;31(6):1378-86
pubmed: 21266983
J Cereb Blood Flow Metab. 2011 Jun;31(6):1387-93
pubmed: 21266984
Antioxid Redox Signal. 2011 May 15;14(10):1777-85
pubmed: 21361730
J Cell Physiol. 2011 Oct;226(10):2484-93
pubmed: 21792905
J Cereb Blood Flow Metab. 2012 Jan;32(1):177-89
pubmed: 21915136
Int J Biochem Cell Biol. 2012 Feb;44(2):262-5
pubmed: 22085530
Anesthesiology. 2012 Jan;116(1):73-83
pubmed: 22129535
Invest New Drugs. 2012 Dec;30(6):2226-35
pubmed: 22392507
Neurotherapeutics. 2012 Jul;9(3):649-57
pubmed: 22711471
Chin Med J (Engl). 2012 Oct;125(19):3472-8
pubmed: 23044308
J Crit Care. 2012 Dec;27(6):743.e1-7
pubmed: 23084134
J Neurosurg Anesthesiol. 2013 Jul;25(3):262-6
pubmed: 23752045
J Clin Invest. 2013 Oct;123(10):4359-63
pubmed: 23999426
Prog Neurobiol. 2014 Apr;115:157-88
pubmed: 24361499
Cell Death Dis. 2014 Jan 09;5:e992
pubmed: 24407245
Lancet. 2014 Jan 18;383(9913):245-54
pubmed: 24449944
J Neural Transm (Vienna). 2014 Aug;121(8):971-9
pubmed: 24623040
Dev Growth Differ. 2014 Apr;56(3):233-44
pubmed: 24645700
Biomed Res Int. 2014;2014:468748
pubmed: 24719869
Cell Mol Neurobiol. 2015 Jan;35(1):17-22
pubmed: 24807461
J Neuroimmunol. 2014 Sep 15;274(1-2):215-24
pubmed: 25091431
Vision Res. 2014 Oct;103:49-62
pubmed: 25152321
World J Stem Cells. 2014 Nov 26;6(5):526-39
pubmed: 25426250
Methods Mol Biol. 2015;1258:209-22
pubmed: 25447866
Neurodegener Dis. 2015;15(4):233-42
pubmed: 26113413
J Cereb Blood Flow Metab. 2016 Feb;36(2):292-301
pubmed: 26661174
Pflugers Arch. 2016 Mar;468(3):491-502
pubmed: 26687113
Sci Rep. 2016 Jan 14;6:18587
pubmed: 26766745
Cereb Cortex. 2017 Jul 1;27(7):3724-3735
pubmed: 27390019
Cell Transplant. 2016 Dec 13;25(12):2173-2185
pubmed: 27480476
Biology (Basel). 2016 Oct 08;5(4):
pubmed: 27740595
Sci Rep. 2017 Jan 16;7:40758
pubmed: 28091591
FASEB J. 2017 Apr;31(4):1709-1718
pubmed: 28096234
Front Bioeng Biotechnol. 2017 Jan 23;4:99
pubmed: 28168187
Front Neurol. 2017 Mar 17;8:92
pubmed: 28367138
Brain Behav Immun. 2017 Oct;65:296-311
pubmed: 28587928
Dis Model Mech. 2017 Dec 19;10(12):1433-1438
pubmed: 29259024
Front Neurol. 2018 Feb 06;9:34
pubmed: 29467713
Ann Neurol. 2018 Aug;84(2):260-273
pubmed: 30014516
Mol Cell Biol. 1987 Aug;7(8):2745-52
pubmed: 3670292

Auteurs

María Pérez-Mato (M)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

Ramón Iglesias-Rey (R)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

Alba Vieites-Prado (A)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

Antonio Dopico-López (A)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

Bárbara Argibay (B)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

Héctor Fernández-Susavila (H)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

Andrés da Silva-Candal (A)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

Amparo Pérez-Díaz (A)

Drug Screening Platform/Biofarma Research Group, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Clara Correa-Paz (C)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

Anne Günther (A)

Institute of Complex Systems-Cellular Biophysics (ICS-4), Forschungszentrum Jülich, Jülich, Germany.

Paulo Ávila-Gómez (P)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

M Isabel Loza (M)

Drug Screening Platform/Biofarma Research Group, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Arnd Baumann (A)

Institute of Complex Systems-Cellular Biophysics (ICS-4), Forschungszentrum Jülich, Jülich, Germany.

José Castillo (J)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain.

Tomás Sobrino (T)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain. Electronic address: tomas.sobrino.moreiras@sergas.es.

Francisco Campos (F)

Clinical Neurosciences Research Laboratory (LINC), Department of Neurology, Health Research Institute of Santiago de Compostela (IDIS), Clinical University Hospital, Santiago de Compostela, Spain. Electronic address: francisco.campos.perez@sergas.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH